Clinical trial
Brain GABA Levels and Treatment Response in Major Depressive Disorder
NCT00464711 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00464711 |
|---|---|
| Title | Brain GABA Levels and Treatment Response in Major Depressive Disorder |
| Official title | Brain GABA Levels and Treatment Response in Major Depressive Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Mclean Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 40 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Apr 24, 2007 |
| Last update posted | Jan 4, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: